Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alfacon-1 Alone vs. Combination with Ribavirin in Hepatitis C
NCT00239252Phase 3Completed
- Sponsor
- Astellas Pharma
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfacon-1 in hepatitis C (HCV), sponsored by Astellas Pharma. Status: completed.
02
Drugs
interferon alfacon-1
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00239252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239252.